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Introduction: Central nervous system involvement in rheumatoid arthritis is infrequent. The most frequent
neurological manifestations of rheumatoid arthritis are peripheral neuropathy and cervical spinal cord compression
due to subluxation of the cervical vertebrae. Cerebral rheumatoid vasculitis is an uncommon and serious
complication which can be life-threatening.
Case presentation: A 52-year-old North African Tunisian Caucasian woman presented with a six-week history
of headache. She had suffered seropositive and destructive rheumatoid arthritis for nine years without any
extra-articular complications. Magnetic resonance imaging of the brain with the T2 sequence showed
high-intensity signal images at the frontal and parietal cortico-subcortical junction suggesting hemispheric vasculitis.
Conclusions: Cerebral vasculitis is an infrequent complication in rheumatoid arthritis which is associated with high
morbidity and in some cases can be life-threatening. Early assessment and a high index of suspicion to recognize
such complications are essential in managing these patients.
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Vasculitis is a group of chronic inflammatory diseases in
which the blood vessel is the target of an immune reac-
tion. They can be idiopathic or due to infection, neo-
plasm, collagenoses or drugs. Rheumatoid arthritis (RA)
is a chronic, progressive, systemic inflammatory disorder
in which the joints are the primary target. Inflammatory
central nervous system lesions are infrequent in RA.
Cerebral rheumatoid vasculitis is an uncommon and ser-
ious complication of RA. Most reported cases have led
to the death of the patient especially when cerebral vas-
culitis was associated with systemic rheumatoid vascu-
litis (Table 1). The treatment of such patients must be
effective. There is no standard treatment of this rare
complication. We describe a patient with longstanding
RA and isolated central nervous system vasculitis.
Case presentation
A 52-year-old North African Tunisian Caucasian woman
was admitted with a six-week history of headache to
hospital. She had been diagnosed with seropositive de-
structive RA nine years before, without any extra-* Correspondence: akroutrim@yahoo.fr
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reproduction in any medium, provided the orarticular manifestations. She received methotrexate
7.5mg per week, low doses of prednisone 7.5mg per day
and anti-inflammatory drugs. She presented with a six-
week history of bilateral temporal headaches. There was
no fever or vomiting. Her body temperature was normal
and her blood pressure was 120/60mmHg. Physical
examination revealed typical joint deformities of RA, but
with no subcutaneous nodules or skin lesions. Synovitis
was noted at both wrists as well as at the second and
third metacarpophalangeal joints of both hands. Her
neurological examination was normal including her deep
tendon and plantar reflexes. There was no evidence of
meningitis or focal neurological signs. Her temporal
pulses were brisk and symmetric. Laboratory tests
revealed the following results: erythrocyte sedimenta-
tion rate of 27mm/hour, C-reactive protein of 14mg/l
(normal: <6) and hemoglobin of 14.9mg/DL. The white
blood cell count was normal (8180/mm3) as were her
platelets (380,000/mm3). Liver and kidney function
tests were normal, as well as blood glucose levels. No
obvious infection, disseminated intravascular coagula-
tion, atlanto-axial dislocation or other collagen diseases
were recognized by physical and blood examinations.
Electrophysiological studies showed no evidence of per-
ipheral nerve lesion or denervation. Tests were positiveLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Literature review
Reference Age / Sex Years Pathologic diagnosis Neurological
manifestation
Treatement Outcome
Pirani and Bennet, 1951 [1] 22 Male 16 CP and systemic vasculitis Depressed MS, seizures NR Exitus
Sokoloff and Bunim, 1957 [2] 64 Male 30 CP and systemic vasculitis NR GC Exitus
Johnson et al. 1959 [3] 37 Female 1 year
8 month
CP and systemic vasculitis Seizures GC Exitus
Johnson et al. 1959 [3] 63 Male 3 CP and systemic vasculitis Hemiparesis GC Exitus
Steiner and Gellbloom, 1959 [4] 62 Male 20 CP vasculitis CN dysfunction,
depressed MS
GC Exitus
Ouyang et al. 1967 [5] 58 Female 30 CP vasculitis Seizures, hemiparesis GC Exitus
Ramos and Mandybur, 1975 [6] 63 Male 1 CP and systemic vasculitis Gerstmann syndrome NR Exitus
Watson et al. 1977 [7] 54 Female 20 CP vasculitis CN dysfunction, aphasia,
hemiparesis, ataxia
GC Exitus
Kiss et al. 2006 [8] 51 Female 39 CP and systemic vasculitis Hemiparesis GC immunoglobulin Exitus
Rodriguez et al. 2006 [9] 49 Female 10 CP vascultis Aphasia, hemianopia GC cyclophosphamide Improvement
Rodriguez et al. 2006 [9] 70 Female Recent
diagnosis
CP vascultis Seizures GC cyclophosphamide Improvement





Caballol Pons et al. 2010 [11] 71 Female 15 CP vascultis Headache, dysarthria High-dose GC Improvement
Ohno et al. 1994 [12] 46 Female 16 CP vasculitis dysarthria and
left hemiparesis
methotrexate therapy Improvement
Present case 52 Female 9 CP vascultis Headache Intensification MTX
therapy
Improvement
CN, cranial nerve; CP, cerebral parenchymal; GC, glucocorticoid; MTX, methotrexate; MS, mental status; NR, not reported.
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antibodies (1/640). Her serum complement, circulating
immune complexes, and antineutrophil cytoplasm anti-
bodies were normal. The fundus examination and the
fluorescein angiography did not reveal any signs of
vasculitis. Magnetic resonance imaging (MRI) of her
brain with the T2 sequence showed high-intensity signal
images at the frontal and parietal-cortico-subcortical
junction suggesting hemispheric vasculitis (Figures 1, 2).
Our patient had not had any severe neurological mani-
festation or any systemic non-neurological manifest-
ation. She suffered only from persistent headache.
Intensification of the methotrexate therapy (15mg per
week) was enough to give a good outcome. Her head-
ache disappeared in two weeks and there were no
symptoms of meningitis or focal neurological signs after
four months.
Discussion
It is well documented that collagen diseases, such as
systemic lupus erythematosis (SLE), Sjögren’s syn-
drome, and Behçet’s disease, are often complicated by
cerebrovascular disorders [13]; however, these seldom
occur in RA [14]. The rate of occurrence of cerebral
vasculitis in patients with RA is 1% to 8% [15]. Neuro-
logical manifestations in patients with RA can be due
to inflammatory central nervous system lesions. Theyhave been described traditionally in seropositive
patients with long-standing, active and erosive RA,
with subcutaneous nodules and extra-articular manifes-
tations [11]. In our case, the RA was seropositive, ac-
tive and erosive but the patient had no extra-articular
signs especially no subcutaneous nodules. Cerebral vas-
culitis is usually associated with severe general signs as
well as prominent extra-articular manifestations with
minimal joint manifestations [10].
Our patient had no extra-articular manifestations
other than those related to cerebral vasculitis. Neuro-
logical involvement in RA includes atlantoaxial sublux-
ation, polymyositis, mononeuritis multiplex, peripheral
neuropathy, rheumatoid nodules in the central or per-
ipheral nervous system, and rheumatoid vasculitis caus-
ing stroke and/or neuropathy [13]. The neurological
manifestations of rheumatoid cerebral vasculitis include
focal signs such as hemiplegia, partial epilepsy, cranial
nerve involvement, or visual field loss, altered con-
sciousness, confusion, and cognitive impairment or de-
mentia [10]. In our case, vasculitis is revealed by severe
and persistent headache which is a common symptom
and may suggest giant cell arteritis, particularly as this
condition can occur in patients with RA [16]. The pres-
ence of temporal pulse and the normality of the fundu-
scopy, especially the absence of vasculitis signs,
militated against giant cell arteritis. Patients with a
Figure 1 Cerebral magnetic resonance imaging. T2-weighted image demonstrates high-intensity-signal involving white matter of two cerebral
hemispheres.
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bral parenchyma are infrequent [1-9]. Eight specified
cases were considered to show isolated cerebral vascu-
litis, and six other cases were associated with symp-
toms indicating systemic rheumatoid vasculitis. The
present case report is similar to the majority of previ-
ously reported cases in that our patient displayed an
isolated central nervous system vasculitis. We did not
detect any other visceral vasculitis. Our patient had a
long-standing history of RA, which required steroid
therapy and the diagnosis of rheumatoid cerebral vas-
culitis was made by cerebral MRI. Other causes of
cerebral vasculitis were eliminated as far as possible
based on past history, physical findings, clinical data,
laboratory studies, and response to the therapy.
Biopsy of the brain is not systematic. Actually, neurora-
diological analysis can be useful for detecting cerebral
vascular disorders. In our case, T2-weighted MRI showed
high signal intensity in the frontal and parietal cortico-
subcortical junction, however, no obvious abnormalitywas detected on T1-weighted MRI. Glucocorticoids at
different dosages and administrations have been reported
in the treatment of central nervous system rheumatoid
vasculitis. Several alternatives such as azathioprine [17],
intravenous immunoglobulins [8] and cyclophosphamide
[9,18] are available for patients with corticosteroid-
resistant or refractory vasculitis. In our case, the intensifi-
cation of the methotrexate therapy was enough to give a
good outcome, especially as there were no symptoms of
systemic vasculitis. Tatsuharu Ohno [12] reported the suc-
cessful management of cerebral vasculitis in a 46-year-old
woman who presented with sudden dysarthria and left
hemiparesis after the initiation of the methotrexate
therapy [12]. Although high doses of glucocorticoid and
cyclophosphamide were used, the cases associated with
systemic rheumatoid vasculitis had the worst prognosis.
Conclusions
Neurological involvement in rheumatic disease is asso-
ciated with high morbidity and, in some cases, can be
Figure 2 Cerebral magnetic resonance imaging. T2 sequence, axial section demonstrates high signal in the subcortical area of the frontal and
parietal lobes.
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suspicion for recognized complications are essential in
managing such patients. Although serious neurological
complications in rheumatic disease appear to be rare,
few studies have been conducted on their prevalence.
Studies of larger cohorts of patients in multi-center set-
tings are required to assess the management of such
patients more fully.Consent
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